Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling
|
Research Initiative
|
FDA
|
NIDCD, NIDCR
|
2010
|
|
Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2014
|
|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCMHD, NHLBI, NIAID, NICHD, NIEHS, NINR
|
2009
|
|
Technology Transfer Policy Board
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIAID, NIMH, OD/ OER, OD/ OIR/ OTT, OD/ OSP
|
1994
|
|
The American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
Unknown
|
|
The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
|
Research Initiative
|
FDA
|
NCCIH, NIA, NIBIB, NIDA, NIDCD, NIMH, NINDS, OD/ DPCPSI/ OBSSR
|
2014
|
|
The Critical Path Institute (C-Path) International Neonatal Consortia (INC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NICHD
|
2015
|
|
The Critical Path Institute (C-Path) Global Pediatrics Trials Consortium
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2015
|
|
The Effect of Various Drugs on the Retina
|
Research Initiative
|
FDA
|
NEI
|
2014
|
|
The Federal Tuberculosis Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
NCI
|
2012
|
|
The Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDDK
|
2013
|
|
The Interagency Committee on Human Nutrition Research (ICHNR) Dietary Guidelines Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD, NIDDK, OD/ DPCPSI/ ODS
|
1983
|
|
The Intersection of Violence and HIV Risk in Women Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
OD/ DPCPSI/ OAR
|
2012
|
|
The MDEpiNet TMJ RoundTable
|
Meeting/ Workshop
|
AHRQ, FDA
|
NIDCR
|
2016
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB, OD/ OSP
|
2001
|
|
The Science of Sex and Gender in Human Health
|
Training Initiative
|
FDA
|
OD/ DPCPSI/ ORWH
|
2006
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2009
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIEHS, NIMH, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP
|
2003
|
|
Tobacco Product Disease Risks
|
Research Initiative
|
FDA
|
NCI
|
2016
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIDCR, NIEHS, OD/ DPCPSI/ ODP, OD/ OER
|
2012
|
|
Tox21 - Memorandum of Understanding on High Throughput Screening, Toxicity Pathway Profiling, and Biological Interpretation of Findings
|
Research Initiative
|
FDA
|
NCATS, NIEHS
|
2010
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2009
|
|
Trans-NIH Plan for HIV-Related Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
CSR, FIC, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH
|
1994
|
|
Transformation of PROWL Survey into Electronic Form.
|
Health Survey
|
FDA
|
NEI, NLM
|
2016
|
|
Treating for Two Interagency Working Group (Medications in Pregnancy)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NICHD, OD/ DPCPSI/ ORWH
|
2012
|
|
Treating for Two: Safe Medication Use in Pregnancy Initiative
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, OD/ DPCPSI/ ORWH
|
2012
|
|
Tularemia Animal Model Qualification Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2013
|
|
|